Skip to main content
. 2018 Mar 14;33(1):651–656. doi: 10.1080/14756366.2018.1444608

Scheme 1.

Scheme 1.

Reagents and conditions: (a) (S)-1-Boc-3-hydroxypyrrolidine, anhydrous THF, NaH, rt, overnight, 70%; (b) 6-methoxy-3-pyridinylboronic acid, Na2CO3, PdCl2 (dppf), DME/H2O, reflux, 4 h, 65–81%; (c) (i)TFA, CH2Cl2, rt, 2 h, 23–91%; (ii) diverse acids, DMF, HATU, DIPEA, rt, 12 h, 23–91%; (d) (S)-1-Boc-3-aminopiperidine, DMF, DIPEA, 90 °C, 6 h, 90%; (e) 1-Boc-4-aminopiperidine, DMF, DIPEA, 90 °C, 6 h, 52%.